Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method

Cancer Research

Volumn 63, Issue 7, 2003, Pages 1449-1453

  Hogervorst, Frans B L ^a   Nederlof, Petra M ^a   Gille, Johan J P ^b   McElgunn, Cathal J ^c   Grippeling, Maartje ^b   Pruntel, Roelof ^a   Regnerus, Rein ^a   Van Welsem, Tibor ^a,c   Van Spaendonk, Resie ^b   Menko, Fred H ^b   Kluijt, Irma ^a,d   Dommering, Charlotte ^a,b   Verhoef, Senno ^a,d   Schouten, Jan P ^c   Van'T Veer, Laura J ^a   Pals, Gerard ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MRC HOLLAND   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; GENE DELETION; GENE DUPLICATION; GENE REARRANGEMENT; HUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL;

BLOTTING, SOUTHERN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE DELETION; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 0037380994     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Puget, N., Stoppa-Lyonnet, D., Sinilnikova, O. M., Pages, S., Lynch, H. T., Lenoir, G. M., and Mazoyer, S. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res., 59: 455-461, 1999.
2. Casilli, F., Di Rocco, Z. C., Gad, S., Tournier, I., Stoppa-Lyonnet, D., Frebourg, T., and Tosi, M. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments. Hum. Mutat., 20: 218-226, 2002.
3. Unger, M. A., Nathanson, K. L., Calzone, K., Antin-Ozerkis, D., Shih, H. A., Martin, A. M., Lenoir, G. M., Mazoyer, S., and L. W. B. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am. J. Hum. Genet. 67: 841-850, 2000.
4. Petrij-Bosch, A., Peelen, T., van Vliet, M., van Eijk, R., Olmer, R., Drusedau, M., Hogervorst, F. B., Hageman, S., Arts, P. J., Ligtenberg, M. J., Meijers-Heijboer, H., Klijn, J. G., Vasen, H. F., Cornelisse, C. J., van't Veer, L. J., Bakker, E., van Ommen, G. J., and Devilee, P. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat. Genet., 17: 341-345, 1997.
5. Puget, N., Sinilnikova, O. M., Stoppa-Lyonnet, D., Audoynaud, C., Pages, S., Lynch, H. T., Goldgar, D., Lenoir, G. M., and Mazoyer, S. An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? Am. J. Hum. Genet., 64: 300-302, 1999.
6. Swensen, J., Hoffman, M., Skolnick, M. H., and Neuhausen, S. L. Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum. Mol. Genet., 6: 1513-1517, 1997.
7. Rohlfs, E. M., Puget, N., Graham, M. L., Weber, B. L., Garber, J. E., Skrzynia, C., Halperin, J. L., Lenoir, G. M., Silverman, L. M., and Mazoyer, S. An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer, 28: 300-307, 2000.
8. Montagna, M., Santacatterina, M., Torri, A., Menin, C., Zullato, D., Chieco-Bianchi, L., and D'Andrea. E. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families. Oncogene, 18: 4160-4165, 1999.
9. Schouten, J. P., McElgunn, C. J., Waaijer, R., Zwijnenburg, D., Diepvens, F., and Pals, G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res., 30: e57, 1-13, 2002.
10. Gille, J. J., Hogervorst, F. B., Pals, G., Wijnen, J., van Schooten, R. J., Dommering, C. J., Meijer, G. A., Craanen, M. E., Nederlof, P. M., de Jong, D., McElgunn, C. J., Schouten, J. P., and Menko, F. H. Genomic deletions of MSH2 and MLHI in colorectal cancer families detected by a novel mutation detection approach. Br. J. Cancer, 87: 892-897, 2002.
11. Shattuck-Eidens, D., McClure, M., Simard, J., Labrie, F., Narod, S., Couch, F., Hoskins, K., Weber, B., Castilla, L., Erdos, M., and et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA, 273: 535-541, 1995.
12. Brown, M. A., Xu, C. F., Nicolai, H., Griffiths, B., Chambers, J. A., Black, D., and Solomon, E. The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene, 12: 2507-2513, 1996.
13. Ligtenberg, M. J., Hogervorst, F. B., Willems, H. W., Arts, P. J., Brink, G., Hageman, S., Bosgoed, E. A., Van der Looij, E., Rookus, M. A., Devilee, P., Vos, E. M., Wigbout, G., Struycken, P. M., Menko, F. H., Rutgers, E. J., Hoefsloot, E. H., Mariman, E. C., Brunner, H. G., and van't Veer, L. J. Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2. Br. J. Cancer, 79: 1475-1478, 1999.
14. Smith, T. M., Lee, M. K., Szabo, C. I., Jerome, N., McEuen, M., Taylor, M., Hood, L., and King, M. C. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res., 6: 1029-1049, 1996.